Become a Member

SoGiAm

Microblogs

AI Business http://aibusiness.org/ Our story – Transforming tomorrow’s enterprises through the evolution of AI – AIBusiness via Peter Xing (@peterxing) EXCLUSIVE: The first ever AI for business landscape map! Register to receive your High Definition map http://aibusiness.org/the-ai-business-environment/ AI is already here. It’s happening in many, if not most industries; its application in the business environment […]

This tread is created for serious cannabis investors to share K.A.S.H. by providing ideas, diligence, links, equities, etc. with like-minded individuals.

I recently discovered tipranks.com and subscribed to the basic (free) service. The site not only lists analysts but equities (stocks), bloggers and insiders. I am fond of investment tools and have shared many here: http://www.stockgumshoe.com/2014/11/first-steps-and-favorite-tools-for-new-investors/ Insiders accumulating shares is perhaps one of the best predictors of an equity’s appreciation over time. According to Investopedia: Insider […]

CES is a global consumer electronics and consumer technology trade show that takes place every January in Las Vegas, Nevada. January 6-9, 2016 CES 2016: Preview of the Las Vegas tech showcase: http://www.bbc.com/news/technology-35192737 CES 2016 home: https://www.cesweb.org/ What will be revealed? Happy 2016 ALL! Best2You-Ben

A brief factual video about H2O as an introduction: https://www.youtube.com/watch?v=VIaw5mCjHPI This discussion thread is dedicated to to the many facets of H2O and how we may conserve, share, transport, desalinate etc. and profit from this essential life giving resource that is now approaching a global crisis in many areas of our planet. Best2ALL!-Ben

The purpose of this thread is to provide Irregulars with a chronological discussion of $NBRV only. Nabriva – Home: http://www.nabriva.com/ $NBRV IPO is tentatively September 18, 2015 at 15-17 USD and shall trade on the Nasdaq Global Market. $NBRV’s lead program is BC-3781: http://newdrugapprovals.org/2014/03/31/bc-3781-a-pleuromutilin-by-nabriva-austria-in-phase-2/ My sincere thanks goes to Dr. KSS, Travis, Lynne and the […]

This thread is designed to allow Irregulars to discuss, share and provide input for calender catalyst events, primarily but not limited to equities contained on the Green Tab of the KSS Da Man! spreadsheet that is maintained by Hi Pockets. The calender currently can be updated only by Benny, Lawrence, Dr. KSS and myself. The […]

This schedule shall be maintained by any IRR as a(n) event(s) occur(s) in the following format: $XYZ, Link/source,. Calculated columns/cells (TBD) may include: SP, %age SP change, Volume, MC, etc.; brief summary/comment including original comment(s)/thread(s)s/post#(s) . 125-150 characters (max), author. Schedule to exist on stockgumshoe.com/microblog utilizing google drive. This spreadsheet greatly reduce the biotech posts […]

Travis- I so much appreciate and enjoy you and the exceptional irregular-shoes here. I have several thoughts/ideas I’d like share: Have you ever considered: 1. A ”Beyond the decimal” (sub penny) and/or pre- and after-market discussion area(s)? 2. An investor tools link area i.e. finvis, barchart, bloomberg, otcmarkets, zacks etc, not only for links but […]

Recent Author Comments

On Friday File: What To Do With Brookfield?

$BAM SA article: https://seekingalpha.com/article/4566008-brookfield-asset-management-could-change-your-life Best![...]

Go to Comment »
On Friday File: Nibbling on High Yields

Merry Christmas and Happy Holidays ALL! LOVE Rules the Universe! Best Alwayz![...]

Go to Comment »
On Microblog: Traders

Highly recommend following r @rauItrades on @twitter Best Alwayz![...]

Go to Comment »
On Microblog: Traders

r @rauItrades If you do not have the screen capacity to have them all visible at once to identify precise price action.Each tab is the following.10/50/200 20/100/250 30/60/90 + 33/66/99 + 11/44/88 + 22/55/77 + 19/37/73/143/279/548.These [...]

Go to Comment »
On Microblog: Wow! You guyz and galz are incredible :-)

Stonehenge & Milkywayhttps://i.pinimg.com/564x/c5/95/43/c595437e49b5650c675133768b812354.jpg[...]

Go to Comment »
On Microblog: Wow! You guyz and galz are incredible :-)

Peace https://pbs.twimg.com/media/FkNTChOXoAIgW1e?format=jpg https://twitter.com/natural_views2/status/1604217204622458880?s=20&t=EjakNo941G1Xyd3tMkQlcQ[...]

Go to Comment »
On Microblog: AI - Artificial Intelligence

HT @bowzachary[...]

Go to Comment »
On Microblog: AI - Artificial Intelligence

#ArtificialIntelligence has become integrated into the #DNA of every domain of the operational world. @drgauravchandra's article looks at transformational #AI trends in #2023 that will continue to shape our planet. https://buff.ly/3v1t6UE #TheYuan2023AI[...]

Go to Comment »
On Friday File: What To Do With Brookfield?

Brookfield Corporation (BN) Stock Forecast & Price Target from @Tipranks $BN https://www.tipranks.com/stocks/bn/forecast Thank YOU Travis for this excellent analysis of Brookfield et al Best to all[...]

Go to Comment »
On An End of Life Narrative – December 2022

Off topic sharing People With Complete Paralysis Walk Again After Nerve Stimulation BreakthroughFirst mice, then humans - Swiss scientists restored the function of "walking neurons" in patients with complete paralysis.https://www.sciencealert.com/[...]

Go to Comment »
On Microblog: Brookfield

$BAM $BN See Travis's Friday file this week. Extra ordinally prescient![...]

Go to Comment »
On Microblog: Any good paid service for daily options trading ?

Tasty Trades[...]

Go to Comment »
On Microblog: PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )

$APTO Form 424b5 http://archive.fast-edgar.com/20221212/AA23MQ2CZ22ENZZZ272B2ZE5HGDRZZ22Z242/ Best Alwwayz[...]

Go to Comment »
On Microblog: PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )

$ONCT Oncternal Therapeutics Presents Updated Interim Data for Zilovertamab in Combination with Ibrutinib at ASH 2022 https://www.1stoncology.com/blog/oncternal-therapeutics-presents-updated-interim-data-for-zilovertamab-in-combination-with-ibrutinib-at-a[...]

Go to Comment »
On Microblog: PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )

#APTO full poster link at #ASH22 A Phase 1/2 Open-label, Multicenter, Dose Escalation and Expansion Study of the Myeloid Kinase Inhibitor HM43239 (Tuspetinib) in Patients with Relapsed or Refractory Acute Myeloid LeukemiaFull poster link: https://d1[...]

Go to Comment »
On Microblog: PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )

$ASH22 Watching reactions of market for data presented over the weekend #LqqK$APTO$ONCT$APVOMy twitter account is:@H0U SoGiAM on twitterJoe Gantos twiter address is @GantosJLqqKing goodBest to all![...]

Go to Comment »
On Microblog: PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )

$ESPR says its cholesterol drug Nexletol delivered "statistically significant and clinically meaningful" results in a large cardiovascular outcomes study: https://www.esperion.com/news-releases/news-release-details/esperion-announces-clear-cardiovascular-[...]

Go to Comment »
On Microblog: PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )

RXDX - Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb https://ir.prometheusbiosciences.com/news-releases/news-release-details/prometh[...]

Go to Comment »
On Alzheimer’s Disease June 2022 – Possible Signs of Progress

What an Alzheimer’s Controversy Reveals About the Pressures of Academia A prominent research paper is under review for possible fraud. Why is it so hard to correct the record?By David Robert Grimes https://www.theatlantic.com/science/archive/2022/0[...]

Go to Comment »
On Microblog: Storage of Electricity - #Batteries & BIG image

Howdy back at all of you, as well, Penny :-) Best Alwayz![...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info